Survival after secondary cytoreductive surgery and chemotherapy compared with chemotherapy alone for first recurrence in patients with platinum-sensitive epithelial ovarian cancer and no residuals after primary treatment. A registry-based study-Reference-Cited by-同舟云学术

Survival after secondary cytoreductive surgery and chemotherapy compared with chemotherapy alone for first recurrence in patients with platinum-sensitive epithelial ovarian cancer and no residuals after primary treatment. A registry-based study

Published:2018-05-22 Issue:8 Volume:97 Page:956-965
ISSN:0001-6349
Container-title:Acta Obstetricia et Gynecologica Scandinavica
language:en
Short-container-title:Acta Obstet Gynecol Scand

Author:

Szczesny Witold¹²^ORCID,Langseth Hilde²,Myklebust Tor Å.²³,Kaern Janne⁴,Tropé Claes⁵,Paulsen Torbjørn²⁴

Affiliation:

1. Department of Research; Innlandet Hospital Trust; Brumunddal Norway

2. Cancer Registry of Norway; Institute of Population-based Cancer Research; Oslo Norway

3. Department of Research; Møre and Romsdal Hospital Trust; Ålesund Norway

4. Department of Gynecological Oncology; Oslo University Hospital; Radiumhospitalet; Oslo Norway

5. Faculty of Medicine; Department Group of Clinical Medicine; University of Oslo; Oslo Norway

Funder

Inger and John Fredriksen's Foundation for Ovarian Cancer Research

Publisher

Wiley

Subject

Obstetrics and Gynaecology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/aogs.13361/fullpdf

Reference30 articles.

1. Modern management of recurrent ovarian carcinoma. A systematic approach to a chronic disease;Michener;Oncology (Williston Park),2005

2. Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline;Wright;Gynecol Oncol,2016

3. Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d'Investigateurs Nationaux Pour les Etudes des Cancers de l'Ovaire (GINECO);Bois;Cancer,2009

4. Surgical management of recurrent ovarian cancer;Suh;Gynecol Oncol,2016

5. Survival of patients following secondary cytoreductive surgery in ovarian cancer;Berek;Obstet Gynecol,1983

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcomes of secondary cytoreductive surgery in patients with platinum-sensitive recurrent ovarian cancer progressed after prior poly (adenosine diphosphate-ribose) polymerase inhibitors: A retrospective cohort study;European Journal of Surgical Oncology;2024-07

2. Eradication of Isolated Para-Aortic Nodal Recurrence in a Patient with an Advanced High Grade Serous Ovarian Carcinoma: Our Experience and Review of Literature;Medicina;2022-02-06

3. The survival outcome and complication of secondary cytoreductive surgery plus chemotherapy in recurrent ovarian cancer: a systematic review and meta-analysis;Journal of Ovarian Research;2021-07-13

4. Isolated lymph node recurrence in epithelial ovarian cancer: Recurrence with better prognosis?;European Journal of Obstetrics & Gynecology and Reproductive Biology;2020-06

5. The impact of secondary cytoreductive surgery on survival in first recurrence of platinum sensitive epithelial ovarian cancer;European Journal of Gynaecological Oncology;2020